Literature DB >> 19380477

Retraction: Cheng B-Q, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299(14):1669-1677.

Catherine D DeAngelis, Phil B Fontanarosa.   

Abstract

Entities:  

Year:  2009        PMID： 19380477     DOI： 10.1001/jama.2009.640

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study.

Authors:  Jeong Han Kim; Hyung Joon Yim; Kwang Gyun Lee; Seung Young Kim; Eun Suk Jung; Young Kul Jung; Ji Hoon Kim; Yeon Seok Seo; Jong Eun Yeon; Hong Sik Lee; Soon Ho Um; Kwan Soo Byun; Ho Sang Ryu
Journal:  Hepatol Int       Date:  2011-07-05       Impact factor: 6.047

Review 2.  Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.

Authors:  Davide Roccarina; Avik Majumdar; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-10

3.  Research misconduct in low- and middle-income countries.

Authors:  Joseph Ana; Tracey Koehlmoos; Richard Smith; Lijing L Yan
Journal:  PLoS Med       Date:  2013-03-26       Impact factor: 11.069
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.